This website uses tracking technologies, such as cookies, to provide a better user experience. If you continue to use this site, then you acknowledge our use of tracking technologies. For additional information, review our Privacy Policy.
Join Jane and Dick Landesman for a community-building fundraiser to benefit the Cancer Research Institute.
Team CRI runs the 2020 TCS New York City Marathon and helps raise critical funds for highly promising cancer immunotherapy research all around the world.
Join us on September 29, for the first-ever CRI Virtual Awards Gala, hosted by Joel McHale with special appearances by YouTuber Markiplier, Nobel Laureate Dr. James Allison, and musical guest Williams Honor.
SWERVE's core workout with instructor Brian punctuated by cardio bursts will push you hard and leave you breathless. All registration fees go to the Cancer Research Institute.
SWERVE's signature off-the-bike workout driven by the music with instructor Sarah. All registration fees go to the Cancer Research Institute.
SWERVE's core workout with instructor Eddy punctuated by cardio bursts will push you hard and leave you breathless. All registration fees go to the Cancer Research Institute.
SWERVE's signature off-the-bike workout driven by the music with instructor Dyan. All registration fees go to the Cancer Research Institute.
Guests are invited to walk “through” the kitchen at The Pool & The Grill restaurants in the Seagram Building on Sunday, April 26.
The Cancer Research Institute assembles a team to run and raise critical funds for highly promising cancer immunotherapy research.
Jane Landesman hosts her annual Ladies Night Out at the Sailfish Point Club House on Sunday, January 19, 2020.
The Cancer Research Institute assembles a team to run the 2019 TCS New York City Marathon.
CRI.ContactUs
Cancer Research Institute | National Headquarters 29 Broadway, Floor 4 | New York, NY 10006-3111
800-992-2623212-832-9376Staff Directory
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy for non-small cell lung cancer.
Dr. Kunle Odunsi discusses genomic testing, new treatments, and promising clinical trials in immunotherapy for ovarian cancer.